Overcoming the Cold Start Problem in Drug Discovery

35 concepts33 papers1 proposal

Deep learning has transformed our ability to predict drug-target interactions (DTI) and drug-target affinities (DTA). However, a persistent bottleneck remains: the "cold-start" problem. When models encounter entirely novel chemical compounds or previously uncharacterized protein targets, their predictive accuracy frequently plummets (Fokoue et al.; Nguyen et al.).

Why does this happen? Traditional architectures often learn to associate specific, coarse chemical patterns with known outcomes rather than capturing the underlying biological logic of drug action (Pak et al.; Jin et al.). Instead of understanding how a molecule fits into a receptor, the model essentially memorizes the training set's graph topology. To achieve true out-of-distribution generalization, recent architectures shift from global pattern matching to localized, mechanistic reasoning.

Deconstructing Molecules into Hierarchical 3D Geometries

One reason models fail on novel entities is their reliance on flat, 1D representations like SMILES strings for drugs or linear amino acid sequences for proteins. In reality, binding is a physical process dictated by 3D geometry.

To bridge this gap, modern frameworks deconstruct novel entities into universal structural building blocks. For instance, Lv et al. introduced a progressive macro-to-micro 3D modeling scheme that spans from functional groups down to individual atoms. Similarly, Wang et al. explicitly model the hierarchical structure of proteins, mapping simple sequences to complex 3D folds.

By focusing on localized regions, such as the specific "subpockets" of protein binding sites explored by Xia et al., or enriching graphs with chemical prior knowledge as seen in Yang et al., models stop treating a novel protein as an entirely unknown entity. Instead, they recognize it as a novel arrangement of familiar structural motifs, allowing learned physical principles to transfer seamlessly.

Simulating the Atomic Handshake via Token-Level Fusion

Even with rich structural representations, how the drug and target are combined matters. Traditional "late fusion" approaches encode the drug and protein into separate vectors and compute a simple dot product or pass them to a fully connected layer. This treats binding as a static matching problem and fails when either vector is out-of-distribution.

To capture the dynamic nature of molecular binding, researchers have turned to token-level fusion and cross-attention mechanisms. Meng et al. demonstrate that modeling the fine-grained "handshake" between individual drug atoms and protein amino acids via token-level cross-attention dramatically improves cross-domain generalization. This mirrors the early fusion approach of Nguyen et al., which nests a drug’s atomic graph directly inside a protein’s residue graph.

By forcing the model to evaluate interactions at the atom-to-residue level (Fokoue et al.), the network learns localized binding physics. Furthermore, evaluating these interactions from a "reciprocal perspective"—looking at prediction rankings from both the drug's and the protein's point of view simultaneously, as proposed by Dick et al.—acts as an error-correcting mechanism that stabilizes predictions on unseen chemical structures.

Pre-training the Grammar of Chemistry and Biology

When a model encounters a completely new class of drugs, it suffers from a lack of labeled interaction data. To overcome this data scarcity, modern architectures leverage self-supervised foundation models trained on massive corpuses of unlabeled biological and chemical data (Lu et al.).

These foundation models learn the intrinsic "grammar" of molecules. For example, Ouyang et al. utilize pre-trained language models to extract multi-view molecular representations (combining text-like SMILES strings and structural graphs). When applied to target proteins, these pre-trained embeddings allow models like the one developed by Song et al. to maintain high accuracy when assessing drug selectivity against entirely "cold" proteins.

The value of these foundational representations lies in their adaptability. As McConachie demonstrates using Low-Rank Adaptation (LoRA), fine-tuning general chemical foundation models on specific biological modalities yields superior representations that align closely with biological data and generalize effectively to entirely unknown receptors.

Grounding Models in Mechanistic and Network Priors

A final strategy to ensure out-of-distribution generalization is to constrain the model's search space using real-world biological networks and metabolic pathways. Purely statistical models are prone to exploiting shortcuts in the training data, but biological priors force them to learn causal pathways.

Pak et al. achieve this by simulating how a drug perturbs a cell's molecular network via network propagation, ensuring the model tracks the downstream biological logic rather than superficial chemical features. In a similar vein, Kang et al. introduce attention regularization guided by known cytochrome P450 (CYP450) enzymatic interactions. By penalizing the model when its attention weights deviate from established metabolic mechanisms, it achieves robust generalizability to unseen dietary and drug components. Finally, Chen et al. integrate external knowledge graphs with contrastive learning, providing an inductive framework that can reason about entirely new drug pairs by anchoring them to a shared biological context.

Key Foundational Work

When drug discovery meets web search: Learning to Rank for ligand-based virtual screening (2015) — contributed 1 concept elements to this direction.
Interpretable Drug Target Prediction Using Deep Neural Representation (2018) — contributed 1 concept elements to this direction.
History & citationVersion 1 · 2026-10-04

Current · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_cold_start_generalization_47feda7b,
  title = {cold-start generalization},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/cold-start-generalization/rdr_47feda7bfb624064b3ae75611f657078},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}

This exact version (version 1, frozen text):

@misc{lacuna_cold_start_generalization_47feda7b_v1,
  title = {cold-start generalization},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/cold-start-generalization/rdr_47feda7bfb624064b3ae75611f657078/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}
About

These directions overlap with this one through shared papers.

See something wrong? Report a mistake